Formulation and Characterization of Ondansetron Hydrochloride Matrix Tablets for Sustained Drug Delivery
Abstract
The objective of proposed work was to develop Ondansetron Hydrochloride (OND HCl) sustained release matrix tablets for the better treatment of vomiting for extended period of time. Sustained release matrix tablet is the drug delivery system that is designed to achieve a prolonged therapeutic effect by continuously releasing medication over an extended period of time after administration of single dose. The matrix tablets of OND HCl were prepared by direct compression method using varying ratio of hydroxy propyl methyl cellulose (HPMC) and ethyl cellulose. The bends of tablets were evaluated for bulk and tapped density, % compressibility index and angle of repose and powder of all formulations blend exhibited that low interparticle friction and excellent flow characteristics. The prepared matrix tablets were then assessed for different physical tests like consistency of weight, thickness, hardness, friability, drug content and in vitro drug release. Each batch of the OND HCl matrix tablets were of good quality as to hardness, thickness, friability and % medicament content. The in vitro drug release study was done for 2 hours by utilizing paddle technique in 0.1N HCl (pH 1.2) as dissolution media and 6 hours using phosphate buffer (pH 6.8) as dissolution media. The drug release study showed that all formulation FMT-1, FMT-2, FMT-3, FMT-4, FMT-5 and FMT-6 were provide the drug release on sustained manner up to 8 hrs. Amongst the developed matrix tablets formulations, FMT-2 containing ethyl cellulose (100 mg) was optimized as best because FMT-2 show highest drug release profile and promoting the sustained release of drug, which could potentially improve the patient compliance.
Keywords:
Ondansetron HCl, HPMC, Ethyl cellulose, Matrix tablets, Sustained action.DOI
https://doi.org/10.25004/IJPSDR.2019.110408References
Vyas SP, Khar RK. Novel carrier system. In: Vyas SP, Ed (s).Targeted and controlled drug delivery: Novel carrier system. New Delhi: CBS Publishers and distributors, 2008, pp. 41-43.
Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics treatise. New Dehli: Vallabh Prakashan., 1995: pp. 335-337.
Chein YW. Novel drug delivery systems. New York : Marcel Dekker., 1992, pp. 43-47.
Bergström CA, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci. 2004; 22: 387-98.
Chaudhary A, Nagaich U, Gulati N, Sharma VK, Khosa RL. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review. J Adv Pharm Edu Res. 2012; 2: 32-67.
Kumari DS, Vengatesh S, Elango K, Damayanthi RD, Deattu N, Christina P. Formulation and evaluation of floating tablets of ondansetron hydrochloride. Int J Drug Dev Res. 2012; 4: 265-74.
Kumar MP, Prasad MR, Pramod M, Reddy VP. Effect of permeation enhancer on ex-vivo permeation of Ondansetron HCl buccal tablets. Int J Pharm Sci Res. 2011; 2(11): 2841-45.
Strebel A, Siepmann J, Dashevsky A, Bodmeier R. pH-independent release of a weakly basic drug from water-insoluble and soluble matrix tablets. J Control Release 2000; 67: 101-10.
Prajapati BG, Patel KR. Design and in-vitro evaluation of Nicorandil sustained release matrix tablets based on combination of hydrophilic and hydrophobic matrix system. Int. J. Pharm Sci Rev Res. 2010; 1(1): 33-38.
Tabandeh H, Mortazavi SA, Guilani TB. Preparation of sustained release matrix tablet of aspirin with ethyl cellulose, eudragit RS 100 and Eudragit S100 and studying the release profiles and their sensitivity to Tablet Hardness. Iranian J Pharma Res. 2003; 201-206.
Harish NM, Charyulu NR, Shenoy KRP. Formulation design and optimization of sustained release tablets of Terbutaline Sulphate. Ind J Pharm Edu Res 2011; 45(3).
Chithaluru K, Tadikonda R, Gollapudi R, Kandula KK. Formulation and in-vitro evaluation of sustained release matrix tablets of losartan potassium. Asian J Pharm Clin Res. 2011; 4(3): 18-22.
Jayanthi, Rashmi M, Shyamala B, Sateesha SB, Sindhu A. pH-independent controlled release swellable matrix tablets. IJRAP. 2011; 2: 577-80.
Published

